Study finds Nyrada’s lead drug can prevent secondary brain injury
Nyrada Inc (ASX:NYR) has reported strong results from a collaborative study into…
Nyrada Inc. (ASX:NYR)
About Nyrada Inc.
Key Information
NYR In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 07/04/2025 | Price Sensitive PS Significant Neuroprotection in Traumatic Brain Injury Study | 340.77KB | 2.9K |
| 31/03/2025 | Price Sensitive PS First Cohort Dosed in Nyradas Phase I Clinical Trial | 229.29KB | 6.2K |
| 17/03/2025 | Nyrada Commences Phase I Clinical Trial Recruitment | 228.94KB | 4.9K |
| 12/03/2025 | 2025 EGM Letter to Shareholders, Notice of Meeting and Proxy | 1.57MB | 298 |
| 18/02/2025 | Nyrada Half Year Results FY2025 | 313.46KB | 23K |
| 18/02/2025 | Price Sensitive PS Appendix 4D and Half Year Report to 31 December 2024 | 458.23KB | 322 |
| 07/02/2025 | Price Sensitive PS Nyrada to Commence Phase Ia Clinical Trial | 233.68KB | 3.0K |
| 23/01/2025 | Price Sensitive PS Quarterly Activities Report and Appendix 4C | 461.69KB | 16K |